Memory markers in the continuum of the Alzheimer’s clinical syndrome

Abstract Background The individual and complementary value of the Visual Short-Term Memory Binding Test (VSTMBT) and the Free and Cued Selective Reminding Test (FCSRT) as markers to trace the AD continuum was investigated. It was hypothesised that the VSTMBT would be an early indicator while the FCS...

Full description

Bibliographic Details
Main Authors: Mario A. Parra, Clara Calia, Vivek Pattan, Sergio Della Sala
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Alzheimer’s Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13195-022-01082-9
_version_ 1811201255805026304
author Mario A. Parra
Clara Calia
Vivek Pattan
Sergio Della Sala
author_facet Mario A. Parra
Clara Calia
Vivek Pattan
Sergio Della Sala
author_sort Mario A. Parra
collection DOAJ
description Abstract Background The individual and complementary value of the Visual Short-Term Memory Binding Test (VSTMBT) and the Free and Cued Selective Reminding Test (FCSRT) as markers to trace the AD continuum was investigated. It was hypothesised that the VSTMBT would be an early indicator while the FCSRT would inform on imminent progression. Methods Healthy older adults (n=70) and patients with mild cognitive impairment (MCI) (n=80) were recruited and followed up between 2012 and 2017. Participants with at least two assessment points entered the study. Using baseline and follow-up assessments four groups were defined: Older adults who were healthy (HOA), with very mild cognitive but not functional impairment (eMCI), and with MCI who did and did not convert to dementia (MCI converters and non-converters). Results Only the VSTMBT predicted group membership in the very early stages (HOA vs eMCI). As the disease progressed, the FCSRT became a strong predictor excluding the VSTMB from the models. Their complementary value was high during the mid-prodromal stages and decreased in stages closer to dementia. Discussion The study supports the notion that neuropsychological assessment for AD needs to abandon the notion of one-size-fits-all. A memory toolkit for AD needs to consider tools that are early indicators and tools that suggest imminent progression. The VSTMBT and the FSCRT are such tools.
first_indexed 2024-04-12T02:18:12Z
format Article
id doaj.art-7fce4b2d60ec4db9ae0e4ee441c3edd0
institution Directory Open Access Journal
issn 1758-9193
language English
last_indexed 2024-04-12T02:18:12Z
publishDate 2022-09-01
publisher BMC
record_format Article
series Alzheimer’s Research & Therapy
spelling doaj.art-7fce4b2d60ec4db9ae0e4ee441c3edd02022-12-22T03:52:12ZengBMCAlzheimer’s Research & Therapy1758-91932022-09-0114111610.1186/s13195-022-01082-9Memory markers in the continuum of the Alzheimer’s clinical syndromeMario A. Parra0Clara Calia1Vivek Pattan2Sergio Della Sala3School of Psychological Sciences and Health, University of StrathclydeSchool of Health in Social Science, University of EdinburghNHS Forth Valley, Stirling Community HospitalHuman Cognitive Neuroscience, Psychology Department, University of EdinburghAbstract Background The individual and complementary value of the Visual Short-Term Memory Binding Test (VSTMBT) and the Free and Cued Selective Reminding Test (FCSRT) as markers to trace the AD continuum was investigated. It was hypothesised that the VSTMBT would be an early indicator while the FCSRT would inform on imminent progression. Methods Healthy older adults (n=70) and patients with mild cognitive impairment (MCI) (n=80) were recruited and followed up between 2012 and 2017. Participants with at least two assessment points entered the study. Using baseline and follow-up assessments four groups were defined: Older adults who were healthy (HOA), with very mild cognitive but not functional impairment (eMCI), and with MCI who did and did not convert to dementia (MCI converters and non-converters). Results Only the VSTMBT predicted group membership in the very early stages (HOA vs eMCI). As the disease progressed, the FCSRT became a strong predictor excluding the VSTMB from the models. Their complementary value was high during the mid-prodromal stages and decreased in stages closer to dementia. Discussion The study supports the notion that neuropsychological assessment for AD needs to abandon the notion of one-size-fits-all. A memory toolkit for AD needs to consider tools that are early indicators and tools that suggest imminent progression. The VSTMBT and the FSCRT are such tools.https://doi.org/10.1186/s13195-022-01082-9Visual Short-Term Memory BindingAlzheimer’s diseaseNeuropsychological assessmentEarly detection
spellingShingle Mario A. Parra
Clara Calia
Vivek Pattan
Sergio Della Sala
Memory markers in the continuum of the Alzheimer’s clinical syndrome
Alzheimer’s Research & Therapy
Visual Short-Term Memory Binding
Alzheimer’s disease
Neuropsychological assessment
Early detection
title Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_full Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_fullStr Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_full_unstemmed Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_short Memory markers in the continuum of the Alzheimer’s clinical syndrome
title_sort memory markers in the continuum of the alzheimer s clinical syndrome
topic Visual Short-Term Memory Binding
Alzheimer’s disease
Neuropsychological assessment
Early detection
url https://doi.org/10.1186/s13195-022-01082-9
work_keys_str_mv AT marioaparra memorymarkersinthecontinuumofthealzheimersclinicalsyndrome
AT claracalia memorymarkersinthecontinuumofthealzheimersclinicalsyndrome
AT vivekpattan memorymarkersinthecontinuumofthealzheimersclinicalsyndrome
AT sergiodellasala memorymarkersinthecontinuumofthealzheimersclinicalsyndrome